Clinical Trial Update: Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing apatinib plus etoposide capsule versus apatinib alone in platinum-resistant ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Apatinib (apatinib)
• etoposide capsule (etoposide)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN